For tirzepatide (Mounjaro), see our Mounjaro dose schedule guide
For women with persistent amenorrhoea, the primary focus should be on correcting low energy availability, as recommended in functional hypothalamic amenorrhoea management guidelines
Tirzepatide is the active ingredient in the brand-name drugs Mounjaro and Zepbound, while semaglutide is the active ingredient in brand-name drugs Ozempic, Wegovy, and Rybelsus
Also seek emergency care for: Persistent vomiting that prevents you from keeping down fluids or medications Signs of dehydration (decreased urination, extreme thirst, dizziness) Vomiting blood Severe upper right abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Progressive abdominal distension with inability to pass gas or stool (possible intestinal obstruction) Contact your healthcare provider within 24-48 hours if you experience persistent nausea or vomiting lasting more than a few days, as this may require dose adjustment or additional management strategies
Many patients find it helpful to link their injection schedule to an existing routine, such as a weekly meal, a specific day of the week, or a daily activity
Consulting your healthcare provider Semaglutide treatment begins with obtaining a prescription from a licensed healthcare provider who understands your specific health needs